RONKONKOMA, N.Y. & PARIS--(BUSINESS WIRE)--Ultrasound heart valve therapy company ReCor Medical announced today the successful completion of a first-in-human procedure using its ultrasound therapy to treat mitral regurgitation (MR). The study data will be presented today at the Transcatheter Cardiovascular Therapeutics (“TCT”) scientific meeting in Washington, D.C.
